Abstract:IntroductionThe aim of our study is to explore the value of serum glycosylated hemoglobin A1c (HbA1c) in disease severity and clinical outcomes of acute pancreatitis (AP).Research design and MethodsPatients with AP were included from January 2013 to December 2020, retrospectively, dividing into normal serum HbA1c level (N-HbA1c) group and high serum HbA1c level (H-HbA1c) group according to the criteria HbA1c <6.5%. We compared patient characteristics, biochemical parameters, disease severity, and clinical outcomes of patients with AP in two groups. Besides, we evaluated the efficacy of serum HbA1c to predict organ failure (OF) in AP patients by receiver operating curve (ROC).ResultsWe included 441 patients with AP, including 247 patients in N-HbA1c group and 194 patients in H-HbA1c group. Serum HbA1c level was positively correlated with Atlanta classification, systemic inflammatory response syndrome, local complication, and OF (all p<0.05). Ranson, BISAP (bedside index of severity in acute pancreatitis), and CT severity index scores in patients with H-HbA1c were markedly higher than those in patients with N-HbA1c (all p<0.01). ROC showed that the best critical point for predicting the development of OF in AP with serum HbA1c is 7.05% (area under the ROC curve=0.79). Logistic regression analysis showed H-HbA1c was the independent risk factor for the development of OF in AP. Interestingly, in patients with presence history of diabetes and HbA1c <6.5%, the severity of AP was significantly lower than that in H-HbA1c group. Besides, there was no significant difference between with and without history of diabetes in N-HbA1c group.ConclusionsGenerally known, diabetes is closely related to the development of AP, and strict control of blood glucose can improve the related complications. Thus, the level of glycemic control before the onset of AP (HbA1c as an indicator) is the key to poor prognosis of AP, rather than basic history of diabetes. Elevated serum HbA1c level can become the potential indicator for predicting the disease severity of AP.

[Relationship Between Glycated Albumin Level and Pancreatic Β Cell Function in Newly Diagnosed Type 2 Diabetics].

Glycated Albumin Level and Its Influential Factors in Type 2 Diabetes Mellitus

Clinical Utility of Glycated Albumin in Type 2 Diabetic Patients

Relationship between glycated albumin and glycated hemoglobin according to glucose tolerance status: A multicenter study

Clinical significance of measurement of glycated albumin in impaired glucose regulation and newly diagnosed diabetes

Elevated Serum HbA1c Level, Rather Than Previous History of Diabetes, Predicts the Disease Severity and Clinical Outcomes of Acute Pancreatitis

Association Between Glycated Albumin and Adverse Outcomes in Patients with Heart Failure.

Primary Assessment of Enzymatic Measurement of Glycated Albumin

Defining the Relationship Between Glycated Albumin and HBA1c in Individuals with a Diverse Spectrum of Glucose Metabolism

Investigation of The Relationgship between Serum Glycated Albumin and Kidney Disfunction with Type 2 Diabetes Mellitus

Glycated albumin:an effective marker for assessing glycemic control in diabetic inpatients

Association of glycosylated albumin and glycosylated hemoglobin A1c with glycemic excursions in elderly type 2 diabetic patients

Relationship of Hemoglobin A1c Withβcell Function and Insulin Resistance in Newly Diagnosed and Drug Naive Type 2 Diabetes Patients

Influence of Insulin Sensitivity and Secretion on Glycated Albumin and Hemoglobin A1c in Pregnant Women with Gestational Diabetes Mellitus

Glycated albumin is superior to glycated hemoglobin for glycemic control assessment at an early stage of diabetes treatment: A multicenter, prospective study

Assessment of enzymatic method for glycated albumin and its correlation research with the diagnosis of diabetes mellitus

Relation Between the Level of Serum CA19-9 and Glucose Control in Inpatients with Diabetes

Association between glycemic control and birthweight with glycated albumin in Chinese women with gestational diabetes mellitus.

Glycated Albumin is a Better Indicator for Glucose Excursion than Glycated Hemoglobin in Type 1 and Type 2 Diabetes

[Combined utility of hemoglobin A1c and glycated albumin in diabetic screening].

Baseline glycated albumin level and risk of type 2 diabetes mellitus in Healthy individuals: a retrospective longitudinal observation in Korea